Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-05 4:14 pm Sale | 2026-05-31 | 13G | APELLIS PHARMACEUTICALS INC CO APLS | Morgan Stanley MS | 0 0.000% | -9,592,751 (Position Closed) | Filing History |
| 2026-05-15 08:37 am Sale | 2026-03-31 | 13G | APELLIS PHARMACEUTICALS INC CO APLS | Deep Track Capital, LP | 4,532,374 3.550% | -2,467,626 (-35.25%) | Filing History |
| 2026-05-15 08:04 am Sale | 2026-03-31 | 13G | APELLIS PHARMACEUTICALS INC CO APLS | RTW Investments, LP | 3,685,045 2.900% | -3,981,719 (-51.93%) | Filing History |
| 2026-05-14 4:36 pm Sale | 2026-05-14 | 13D | APELLIS PHARMACEUTICALS INC CO APLS | BIOGEN INC. BIIB | 0 0.000% | -18,469,475 (Position Closed) | Filing History |
| 2026-05-12 09:51 am Purchase | 2026-03-31 | 13G | APELLIS PHARMACEUTICALS INC CO APLS | STATE STREET CORP STT | 6,845,031 5.400% | 6,845,031 (New Position) | Filing History |
| 2026-04-07 08:06 am Sale | 2026-03-31 | 13G | APELLIS PHARMACEUTICALS INC CO APLS | Wellington Management Group LLP | 249,635 0.200% | -13,500,912 (-98.18%) | Filing History |
| 2026-04-06 6:08 pm Purchase | 2026-03-31 | 13D | APELLIS PHARMACEUTICALS INC CO APLS | BIOGEN INC. BIIB | 18,469,475 14.200% | 18,469,475 (New Position) | Filing History |
| 2026-03-26 3:45 pm Sale | 2026-03-13 | 13G | APELLIS PHARMACEUTICALS INC CO APLS | VANGUARD GROUP INC | 0 0.000% | -9,555,678 (Position Closed) | Filing History |
| 2026-02-17 08:25 am Purchase | 2025-12-31 | 13G | APELLIS PHARMACEUTICALS INC CO APLS | RTW Investments, LP | 7,666,764 6.100% | 7,666,764 (New Position) | Filing History |
| 2026-02-06 12:08 pm Purchase | 2026-01-31 | 13G | APELLIS PHARMACEUTICALS INC CO APLS | BlackRock, Inc. BLK | 13,228,073 10.500% | 7,629,501 (+136.28%) | Filing History |
| 2025-11-14 3:45 pm Sale | 2025-09-30 | 13G | APELLIS PHARMACEUTICALS INC CO APLS | EcoR1 Capital, LLC | 3,447,156 2.700% | -7,725,912 (-69.15%) | Filing History |
| 2025-11-07 08:18 am Purchase | 2025-10-31 | 13G | APELLIS PHARMACEUTICALS INC CO APLS | Wellington Management Group LLP | 13,750,547 10.900% | 4,741,025 (+52.62%) | Filing History |
| 2025-08-12 10:34 am Sale | 2025-06-30 | 13G | APELLIS PHARMACEUTICALS INC CO APLS | Wellington Management Group LLP | 9,009,522 7.200% | -2,823,887 (-23.86%) | Filing History |
| 2025-05-16 4:42 pm Purchase | 2025-05-09 | 13G | APELLIS PHARMACEUTICALS INC CO APLS | Deep Track Capital, LP | 7,000,000 5.570% | 1,000,000 (+16.67%) | Filing History |
| 2025-04-25 4:14 pm Sale | 2025-03-31 | 13G | APELLIS PHARMACEUTICALS INC CO APLS | BlackRock, Inc. BLK | 5,598,572 4.500% | -593,365 (-9.58%) | Filing History |
| 2025-02-10 10:49 am Sale | 2024-12-31 | 13G | APELLIS PHARMACEUTICALS INC CO APLS | Wellington Management Group LLP | 11,833,409 9.500% | -3,766,120 (-24.14%) | Filing History |
| 2025-02-03 1:09 pm Purchase | 2024-12-31 | 13G | APELLIS PHARMACEUTICALS INC CO APLS | Morgan Stanley MS | 9,592,751 7.700% | 9,592,751 (New Position) | Filing History |
| 2024-11-22 4:16 pm Sale | 2024-11-20 | 13G | APELLIS PHARMACEUTICALS INC CO APLS | Deep Track Capital, LP | 6,000,000 4.820% | -220,265 (-3.54%) | Filing History |
| 2024-11-22 08:47 am Purchase | 2024-11-15 | 13G | APELLIS PHARMACEUTICALS INC CO APLS | Deep Track Capital, LP | 6,220,265 5.000% | 6,220,265 (New Position) | Filing History |
| 2024-11-14 1:28 pm Sale | 2024-09-30 | 13G | APELLIS PHARMACEUTICALS INC CO APLS | T. Rowe Price Investment Management, Inc. | 2,985,272 2.500% | -3,318,312 (-52.64%) | Filing History |